Chemoinformaics analysis of 31-Norcycloartenol
Molecular Weight | 412.702 | nRot | 4 |
Heavy Atom Molecular Weight | 364.318 | nRig | 23 |
Exact Molecular Weight | 412.371 | nRing | 5 |
Solubility: LogS | -6.813 | nHRing | 0 |
Solubility: LogP | 7.159 | No. of Aliphatic Rings | 5 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
Atoms Count | 78 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 5 |
No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 29 | No. of Saturated Rings | 5 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 81.2381 |
nHD | 1 | BPOL | 48.1539 |
QED | 0.467 |
Synth | 5.512 |
Natural Product Likeliness | 3.645 |
NR-PPAR-gamma | 0.01 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.005 |
Pgp-sub | 0 |
HIA | 0.007 |
CACO-2 | -4.892 |
MDCK | 0.000011 |
BBB | 0.394 |
PPB | 0.992508 |
VDSS | 2.221 |
FU | 0.0174911 |
CYP1A2-inh | 0.033 |
CYP1A2-sub | 0.396 |
CYP2c19-inh | 0.065 |
CYP2c19-sub | 0.954 |
CYP2c9-inh | 0.098 |
CYP2c9-sub | 0.357 |
CYP2d6-inh | 0.054 |
CYP2d6-sub | 0.509 |
CYP3a4-inh | 0.329 |
CYP3a4-sub | 0.481 |
CL | 22.768 |
T12 | 0.011 |
hERG | 0.374 |
Ames | 0.054 |
ROA | 0.136 |
SkinSen | 0.838 |
Carcinogencity | 0.037 |
EI | 0.017 |
Respiratory | 0.769 |
NR-Aromatase | 0.229 |
Antiviral | No |
Prediction | 0.634121 |